Sight Sciences COO Alison Bauerlein Sells $223K in Company Stock

Sight Sciences Chief Operating Officer Alison Bauerlein sold 25,260 shares of company stock on October 2, 2026, for approximately $223,626. The sale covered tax obligations from the vesting of restricted stock units, according to a regulatory filing.

Bauerlein sold the shares at a weighted average price of $8.853 per share. She maintains a stake in the medical device company, retaining beneficial ownership of 639,449 shares.

Breakdown of Insider Holdings

Following the October 2 transaction, Bauerlein's remaining holdings consist of two components:

• Common Stock: 214,450 shares held directly.
• Restricted Stock Units: 424,999 shares scheduled to be acquired upon the future vesting and settlement of RSUs.

Market Performance and Context

This transaction occurs as Sight Sciences (NASDAQ: SGHT) faces downward pressure in the public markets. As of October 16, 2026, shares of the company were trading at $8.28, a 5.91% decline from the previous market close.

In corporate governance, sell-to-cover transactions are a standard mechanism for executives to satisfy tax liabilities incurred when equity awards vest. Because these sales are triggered by the timing of tax requirements rather than discretionary investment decisions, market observers view them as distinct from voluntary portfolio rebalancing or divestment strategies.